Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Pregnancy and Medication Impact, Microscopic Colitis, and Liver Disease Diagnosis and Treatment.
Hepatocellular carcinoma surveillance in the telehealth era: A single-centre review.
Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero.
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease.
Active Inflammatory Bowel Disease on Intestinal Ultrasound During Pregnancy Is Associated With an Increased Risk of Adverse Pregnancy and Neonatal Outcomes Independent of Clinical and Biochemical Disease Activity.
Widespread pylephlebitis and infective thromboembolism due to <i>Streptococcus anginosus</i>-related appendiceal rupture: A case report.
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease.
A Nonrandomized Pilot Study to Investigate the Acceptability and Feasibility of LivR Well: A Multifaceted 28-Day Home-Based Liver Optimization Program for Acute-on-Chronic Liver Failure.
Innate and Adaptive Immunity is not Impacted by Inflammatory Bowel Disease Medications in Pregnant Women and Their Offspring.
Thiopurine Metabolite Shunting in Late Pregnancy Increases the Risk of Intrahepatic Cholestasis of Pregnancy in Women With Inflammatory Bowel Disease, and Can be Managed With Split Dosing.
Thrombocytosis and Transaminitis in Infants Born to Women With Inflammatory Bowel Disease Is Associated With Exposure to Maternal Inflammation In Utero.
Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitis.
Identifying the real-world challenges of dysplasia surveillance in inflammatory bowel disease: a retrospective cohort study in a tertiary health network.
Metabolic-associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapy.
Feasibility of transperineal intestinal ultrasound in assessing ulcerative proctitis during pregnancy.
Clinical outcomes of hepatocellular carcinoma surveillance in Melbourne, Australia.
Colonic cytomegalovirus DNA detection by polymerase chain reaction does not influence outcomes in inflammatory bowel disease and immunosuppressed cohorts.
Well controlled maternal inflammatory bowel disease does not increase the risk of abnormal neurocognitive outcome screening in offspring.
Identify, screen and treat via electronic pathway: a semiautomated approach to retriaging a liver clinic waitlist.
Gastric intestinal metaplasia: Prevalence in a large Australian center and nationwide survey of endoscopic practice.
Acute-on-chronic liver failure: Controversies and consensus.
Hepatocellular carcinoma surveillance in Australia: current and future perspectives.
An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis.
High incidence of inflammatory bowel disease in Northern Australia: a prospective community population-based Australian incidence study in the Mackay-Isaac-Whitsunday region.
The Effect of In Utero Exposure to Maternal Inflammatory Bowel Disease and Immunomodulators on Infant Immune System Development and Function.
Evaluation and management of ileal pouch-anal anastamosis (IPAA) complications in pregnancy, and the impacts of an IPAA on fertility.
Impact of increased alcohol consumption during the COVID-19-related lockdowns on admissions with liver disease, gastrointestinal bleeding and pancreatitis in Melbourne, Victoria.
Healthcare utilisation and costing for decompensated chronic liver disease hospitalisations at a Victorian network.
Assessing vitamin D as a biomarker in inflammatory bowel disease.
Letter: Transperineal ultrasonography for ulcerative proctitis- Applicability in the pregnant population?